Catalyst Wire Dossier Catalyst Wire Dossier

Rifaximin

rifaximin · Bausch Health Americas, Inc.
Drug timelines are a Plus or Pro feature.

111 regulatory and trial events tracked for Rifaximin, covering 2008-03-18 to 2026-06-22. Get the full timeline:

Most recent: Clinical Trial Results: Rifaximin in Patients With Diabetic Gastroparesis [Phase 2]

See pricing